UPEXI, INC. — Director's Dealing 2022

Nov 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UPEXI, INC. (UPXI)
CIK: 0001775194
Period of Report: 2022-09-30

Reporting Person: Salkind Gene (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-30	Stock Option Grant (right to buy)	$3.87	A	50000	Acquired	2027-09-30	Common Stock (50000)	Direct

Footnotes

F1: The option provides for vesting in equal monthly installments for the two-year period starting on July 1, 2022 and ending on July 1, 2024; therefore, on the grant date of September 30, 2022, such options immediately vested for 3 months and thereafter will continue to vest on a monthly basis for the succeeding 21 months.